Services
PSS helps innovators design and execute commercialization and life cycle strategies, including authorized generic launches, unbranded biologic launches under an existing BLA, and programs that improve diagnostic access and identification of treatment-eligible patients.
Evaluate
Model
Design
Align Partners
Govern Implementation
Small-Molecule Loss-of-Exclusivity Strategy
Authorized Generic & Erosion Planning
Brand-for-Generic Strategy Models
Diagnostic Access & Patient Identification Strategy
Sponsored Testing Program Architecture
Lab & Diagnostic Partner Coordination
Unbranded Biologic Commercialization Strategy
Specialty Channel & Payer Strategy
Operational Launch Governance
Commercialization Governance & Execution
Cross-Functional Launch Coordination
External Partner & Vendor Management
How We Work
NDA-first approach for sensitive commercial and partner discussions.
Structured sourcing and evaluation of external partners, with clear scorecards and governance.
Execution PMO to coordinate vendors and internal workstreams through launch milestones.
PSS does not provide manufacturing services or FDA establishment registration. Where needed, we coordinate qualified external partners for labeling/packaging, logistics, trade operations support, and related workstreams.
Request a focused discussion about a product-specific commercialization decision.
Call:
Email:
Schedule a Meeting:
Please fill out our contact form to request a meeting, and we’ll follow up with our availability.
Upload Securely:
*Do not upload PHI or sensitive personal data. Do not upload confidential information unless an NDA is in place.
LinkedIn: